×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LXEO – lexeo therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LXEO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/8
08:20 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Chardan Capital from $25.00 to $22.00. They now have a "buy" rating on the stock.
Medium
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Chardan Capital from $25.00 to $22.00. They now have a "buy" rating on the stock.
4/8
08:20 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
Medium
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
4/7
06:10 am
lxeo
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study [Yahoo! Finance]
High
Report
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study [Yahoo! Finance]
4/7
06:00 am
lxeo
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
High
Report
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
3/26
08:19 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock.
3/25
11:14 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Royal Bank of Canada from $24.00 to $20.00. They now have an "outperform" rating on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Royal Bank of Canada from $24.00 to $20.00. They now have an "outperform" rating on the stock.
3/25
08:17 am
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
3/24
12:14 pm
lxeo
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
High
Report
Lexeo Therapeutics, Inc. (NASDAQ: LXEO) had its price target lowered by analysts at Leerink Partners from $19.00 to $18.00. They now have an "outperform" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/9
05:48 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Otero Jose Manuel
High
Report
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Otero Jose Manuel
4/9
05:46 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Robertson Jenny
High
Report
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Robertson Jenny
4/9
05:45 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: See Tai Sandi
High
Report
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: See Tai Sandi
4/7
06:07 am
lxeo
Form 8-K Lexeo Therapeutics, Inc. For: Apr 07
High
Report
Form 8-K Lexeo Therapeutics, Inc. For: Apr 07
4/1
07:58 pm
lxeo
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Townsend Richard Nolan
Low
Report
Form 4 Lexeo Therapeutics, Inc. For: Mar 14 Filed by: Townsend Richard Nolan
3/24
04:17 pm
lxeo
Form S-8 POS Lexeo Therapeutics, Inc.
High
Report
Form S-8 POS Lexeo Therapeutics, Inc.
3/24
07:52 am
lxeo
Form 424B5 Lexeo Therapeutics, Inc.
High
Report
Form 424B5 Lexeo Therapeutics, Inc.
3/24
07:05 am
lxeo
Form S-8 Lexeo Therapeutics, Inc.
High
Report
Form S-8 Lexeo Therapeutics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: